Viewing Study NCT01371227


Ignite Creation Date: 2025-12-25 @ 5:19 AM
Ignite Modification Date: 2025-12-26 @ 4:27 AM
Study NCT ID: NCT01371227
Status: COMPLETED
Last Update Posted: 2013-07-04
First Post: 2011-05-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of JNS002 (Doxorubicin Hydrochloride Liposome Injection) in Relapsed or Refractory Multiple Myeloma
Sponsor: Janssen Pharmaceutical K.K.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module